Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.68 USD | -3.16% | 0.00% | -1.60% |
Jun. 07 | Fate Therapeutics, Inc. Appoints J. Scott Wolchko as Principal Financial and Accounting Officer | CI |
May. 31 | Fate Therapeutics, Inc. Announces Chief Financial Officer Changes | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.60% | 419M | |
+18.72% | 125B | |
+14.19% | 108B | |
-4.93% | 24.21B | |
+3.23% | 22.78B | |
-10.44% | 17.96B | |
-41.74% | 16.43B | |
-13.31% | 16.37B | |
+2.44% | 13.58B | |
+27.89% | 11.66B |
- Stock Market
- Equities
- FATE Stock
- News Fate Therapeutics, Inc.
- Insider Sell: Fate Therapeutics